Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep;10(3):1551-1554.
doi: 10.3892/ol.2015.3438. Epub 2015 Jun 30.

Hodgkin's lymphoma associated with myelofibrosis: A case report

Affiliations

Hodgkin's lymphoma associated with myelofibrosis: A case report

Rong Fu et al. Oncol Lett. 2015 Sep.

Abstract

In the present study, the case of a patient with nodular sclerosing Hodgkin's lymphoma (NSHL) presenting with diffuse fibrosis of the bone marrow (BM) was reported. A 30-year-old male complained of fever for 1 year, as well as lumbago, lymph node swelling and night sweats for 3 months. A biopsy of the lymph nodes established a diagnosis of NSHL. Aspiration of BM was a dry tap, and the BM biopsy demonstrated marked myelofibrosis with increased proliferation of reticulin fiber. Multiple skeletal lesions were detected in the patient's vertebra, pelvis, sternum and bilateral femur by magnetic resonance imaging and computed tomography. Following numerous courses of chemotherapy and radiotherapy, remission of the lymphoma was achieved. Subsequently, the BM aspiration became possible, and BM biopsy demonstrated a reduction in fibrosis.

Keywords: Hodgkin's lymphoma; myelofibrosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Microscopic view of the lymph node biopsy specimen, diagnosed with nodular sclerosing Hodgkin's lymphoma (magnification, x40; stain, hematoxylin and eosin).
Figure 2.
Figure 2.
Microscopic view of the bone marrow biopsy specimen, diagnosed with myelofibrosis. Increased proliferation of fibroblasts and reticulin fiber is observed (magnification, x40; stain, hematoxylin and eosin).

References

    1. Younes A. Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma. Hematology. 2009;2009:507–519. doi: 10.1182/asheducation-2009.1.507. - DOI - PubMed
    1. Eichenauer DA, Böll B, Diehl V. Pharmacotherapy of Hodgkin lymphoma: standard approaches and future perspectives. Expert Opin Pharmacother. 2014;15:1139–1151. doi: 10.1517/14656566.2014.909411. - DOI - PubMed
    1. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol. 2005;23:8520–8530. doi: 10.1200/JCO.2004.00.9316. - DOI - PubMed
    1. Tefferi A. Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014;89:915–925. doi: 10.1002/ajh.23703. - DOI - PubMed
    1. Niino D, Tsuchiya T, Tomonaga M, Miyazaki Y, Ohshima K. Clinicopathological features of acute megakaryoblastic leukaemia: Relationship between fibrosis and platelet-derived growth factor. Pathol Int. 2013;63:141–149. doi: 10.1111/pin.12043. - DOI - PubMed

LinkOut - more resources